—
C+
C+ The full Closelooknet — membership. Open the C+ overview

West Pharmaceutical Services Inc (WST) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Company snapshot — West Pharmaceutical Services Inc

WST in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
West Pharmaceutical Services makes the containment and delivery systems that carry injectable drugs: stoppers, seals, syringe and cartridge components, vials and self-injection devices, sold to biologic, generic and pharmaceutical drug companies. A second, smaller business contract-manufactures devices for surgical, diagnostic, ophthalmic and other drug-delivery uses. It is based in Exton, Pennsylvania, and has sold since before most of today's biologics existed.
Where it sits in the stack
West sits outside our chip and data-centre sleeves; it belongs to the healthcare sector, in medical instruments and supplies, as a maker of packaging and delivery components rather than a drug itself.
Who it is priced against
The diary has not placed it in a named peer group; the comparison the market draws is with other injectable-packaging and drug-delivery makers such as Gerresheimer.
Why Closelooknet tracks it
It holds a seat in the S&P 500 but has no Rubin or Halo sleeve, carries no Closelooknet score, and has drawn no mentions or quotes in the diary's editions so far.
What the diary watches
Whether demand for injectable biologics and self-injection devices keeps widening the volume of containment components it ships, and whether that shows up in how the stock trades relative to its own recent range.

West Pharmaceutical Services Inc (WST) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelooknet reading that exists for WST, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 1 analyst action on the wire · latest: price target by Morgan Stanley, 2026-09-22

The Street on this name

Analyst actions and the latest print for WST from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Morgan Stanley — target 400 Target set to $400 (+10.6% to spot) 2026-09-22

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Who it is priced against Medical Instruments & Supplies · United States · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against WST on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Dividends and capital return trailing yield 0.18%, semi-annual · last 0.22 USD on 2026-04-29

Dividends and capital return

What WST pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.66 USD per share · a 0.18% yield on the 2026-09-25 close 3 distributions, paid twice a year 2026-09-25
  • Change on the year +57.6% against the prior twelve months prior twelve months 0.42 USD per share
  • Last distribution 0.22 USD per share as the price series records it, within days of the ex-date 2026-04-29
  • By calendar year 2025: 0.64 USD (partial) · 2026: 0.44 USD to date first distribution recorded in the three-year window: 2025-04-30

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

How it trades on rate days beta 0.43 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How WST has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.43 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), West Pharmaceutical Services Inc moved 0.43% on average · correlation 0.12 · higher than 43% of US names
  • Beta, last 3 months 0.14 less rate-sensitive lately than over the year
  • On the 10 worst bond days +0.10% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.60% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25

FAQ · from the current data · as of 2026-09-26

Quick answers

What is West Pharmaceutical Services Inc (WST)?

West Pharmaceutical Services Inc trades as WST on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is WST in a Closelooknet index?

Not currently — West Pharmaceutical Services Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does WST trade against its moving averages?

Uptrend stack intact: Trades +5.7% vs the 50-day and +23.6% vs the 200-day average, 4% below the 52-week high and +65.6% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

What does West Pharmaceutical Services Inc do?

West Pharmaceutical Services makes the containment and delivery systems that carry injectable drugs: stoppers, seals, syringe and cartridge components, vials and self-injection devices, sold to biologic, generic and pharmaceutical drug companies. A second, smaller business contract-manufactures devices for surgical, diagnostic, ophthalmic and other drug-delivery uses. It is based in Exton, Pennsylvania, and has sold since before most of today's biologics existed. The diary has not placed it in a named peer group; the comparison the market draws is with other injectable-packaging and drug-delivery makers such as Gerresheimer.

Where does West Pharmaceutical Services Inc sit in the AI build-out?

West sits outside our chip and data-centre sleeves; it belongs to the healthcare sector, in medical instruments and supplies, as a maker of packaging and delivery components rather than a drug itself. It holds a seat in the S&P 500 but has no Rubin or Halo sleeve, carries no Closelooknet score, and has drawn no mentions or quotes in the diary's editions so far.

Does West Pharmaceutical Services Inc pay a dividend?

West Pharmaceutical Services Inc has paid 0.66 USD per share over the last twelve months, paid twice a year, a trailing yield of 0.18% on the 2026-09-25 close; the last distribution recorded in the price series was 0.22 USD on 2026-04-29. The "Dividends and capital return" block on this page carries the lines.

How does West Pharmaceutical Services Inc trade when bond yields rise?

Over the past year West Pharmaceutical Services Inc had a beta of 0.43 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 43% of US names. On the 10 sessions in which long bonds fell most it moved +0.10% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What has Wall Street done on West Pharmaceutical Services Inc recently?

The most recent analyst action on West Pharmaceutical Services Inc on the Closelooknet wire is a price target by Morgan Stanley on 2026-09-22 (target 400). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for WST, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.